Document Leak: NICE Says No to MS

Pharmaceutical Executive

Pharmaceutical Executive, Pharmaceutical Executive-09-01-2001, Volume 0, Issue 0

London-Schering and Biogen have both expressed anger over the leak of a National Institute of Clinical Excellence (NICE) document suggesting that doctors stop prescribing beta-interferon to new multiple sclerosis (MS) patients.